TrialLeukemia & lymphoma2010

Experience with everolimus (RAD001), an oral mammalian target of rapamycin inhibitor, in patients with systemic mastocytosis.

Sameer A Parikh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.